Known targets — ChEMBL curated mechanism
ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Iodide SCHEMBL7217076 | 0.95 | GBA1 (0.35) | GBA1GAADRD2 | |
| Hydrochloric Acid SCHEMBL7216868 | 0.95 | GBA1 (0.35) | GBA1GAADRD2 | |
| Bromide SCHEMBL4652944 | 0.85 | GBA2 (0.39) | GBA1GAA | |
| Bromide SCHEMBL4651690 | 0.83 | GNAI3 (0.42) | GBA1GAA | |
| SCHEMBL27485494 | 0.82 | GBA2 (0.40) | GBA1GAA | |
| Bromide SCHEMBL4651634 | 0.81 | GNAI3 (0.46) | GBA1GAA | |
| Hydrochloric Acid SCHEMBL7224242 | 0.80 | GNAI3 (0.39) | GBA1GAA | |
| Iodide SCHEMBL7218749 | 0.80 | GBA2 (0.39) | GBA1GAA | |
| Trifluoroacetic Acid SCHEMBL7967443 | 0.80 | DRD2 (0.42) | GBA1DRD2 | |
| Hydrochloric Acid SCHEMBL7224340 | 0.78 | GNAI3 (0.47) | GBA1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2003124-B1 | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III | CHATHAM BIOTEC LTD (CA) | 2015-02-25 | — | — | EP | disclosed |
| EP-2003124-A1 | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III | Chatham Biotec Ltd (CA) | 2008-12-17 | — | — | EP | disclosed |
| EP-1727810-B1 | SEMI-SYNTHESIS OF TAXANE INTERMEDIATES FROM 9-DIHYDRO-13-ACETYLBACCATIN III | CHATHAM BIOTEC LTD (CA) | 2008-10-01 | — | — | EP | disclosed |
| US-7202370-B2 | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III | CONOR MEDSYSTEMS, INC. (US) | 2007-04-10 | — | — | US | disclosed |
| EP-1727810-A2 | SEMI-SYNTHESIS OF TAXANE INTERMEDIATES FROM 9-DIHYDRO-13-ACETYLBACCATIN III | Chatham Biotec Ltd. (CA) | 2006-12-06 | — | — | EP | disclosed |
| WO-2005044811-A2 | SEMI-SYNTHESIS OF TAXANE INTERMEDIATES FROM 9-DIHYDRO-13-ACETYLBACCATIN III | PHYTOGEN LIFE SCIENCES INC. (CA) | 2005-05-19 | — | — | WO | disclosed |
| US-20050101789-A1 | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III | PHYTOGEN LIFE SCIENCES INC. (CA) | 2005-05-12 | — | — | US | disclosed |
| US-6632949-B2 | Difluoro-diamine methylene derivatives | MITSUI CHEMICALS, INC. (JP) | 2003-10-14 | — | — | US | disclosed |
| US-20030004348-A1 | Halogenating agents | SONODA HIROSHI (JP) | 2003-01-02 | — | — | US | disclosed |
| US-6458990-B1 | BIS(DIHYDROCARBYLAMINO)DIFLUOROMETHANE OR CYCLIC DERIVATIVES THEREOF; FORMING BY REACTING ALKALI METAL HALIDE WITH THE CORRESPONDING AMIDINIUM SALT; FLUORINATION OF ALCOHOLS, THIOPHENOLS, ALDEHYDES, AND KETONES | MITSUI CHEMICALS, INC. (JP) | 2002-10-01 | — | — | US | disclosed |
| EP-0949226-B1 | Process for the preparation of acetylene derivatives | MITSUI CHEMICALS INC (JP) | 2002-07-17 | — | — | EP | disclosed |
| US-20020042521-A1 | Nitrogen-based halogenating agents and process for preparing halogen-containing compounds | SONODA HIROSHI (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6329529-B1 | FOR FLUORINATING OF ORGANIC COMPOUNDS, EFFICIENCY, POLLUTION CONTROL | MITSUI CHEMICALS, INC. (JP) | 2001-12-11 | — | — | US | disclosed |
| US-6127583-A | Process for preparing acetylene derivative from a ketone compound | MITSUI CHEMICALS, INC. (JP) | 2000-10-03 | — | — | US | disclosed |
| EP-0949226-A1 | Process for the preparation of acetylene derivatives | Mitsui Chemicals, Inc. (JP) | 1999-10-13 | — | — | EP | disclosed |
| EP-0895991-A2 | Halogenating agent | Mitsui Chemicals, Inc. (JP) | 1999-02-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050101789-A1 | Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III | CIAPIN1, TUBB3, ACACB | GBA1 2395/4885GAA 3124/4885DRD2 2480/4885 |
| US-20030004348-A1 | Halogenating agents | AFF1, NAF1, AFF2 | GBA1 150/4885GAA 3779/4885DRD2 384/4885 |
| US-20020042521-A1 | Nitrogen-based halogenating agents and process for preparing halogen-containing compounds | AFF1, NAF1, CYP2F1 | GBA1 276/4885GAA 4030/4885DRD2 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.